verified COP 3,1 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q2 — Pharmacology (medical) lock Subscription

Clinical Therapeutics

Clinical Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 153. It has a COP Index of 3,1 (best band Q2). It is published in English. It has a COP Index of 3,1.

Clinical Therapeutics focuses its scope in these topics and keywords: healthy, patients, pharmacokinetics, review, treatment, chinese, administered, drug, combination, gastrointestinal, ...

ISSN: 0149-2918

Publisher: Elsevier Inc.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

COP Index trending_up

3,1 Q2

64 of 216 journals in Pharmacology (medical)

H-index · SJR 153 · 0,978

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

3,1

SJR Impact

0,978

H-index

153

Docs (year)

202

Docs 3y

561

Total refs

6978

Cites 3y

1709

Citable 3y

470

Cites/Doc 2y

3.02

Ref/Doc

34.54

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe

Viscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee

Disease management contracting: legal issues

Compliance of pediatric patients with treatment involving antibiotic suspensions: A pilot study

Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy

Comparative bioavailability of ceftibuten in capsule and suspension forms

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

SHOW MORE ARTICLES

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

A cost-of-illness study of lyme disease in the United States

Assessing the input costs of disease management programs

An outpatient prescription-medication benefit in medicare: So much time, so little consensus

An immunophilin-binding assay for sirolimus

An estradiol matrix transdermal system for the prevention of postmenopausal bone loss

Amlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients

A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

A disease management case study on asthma

FAQs

Clinical Therapeutics has a COP Index of 3,1 (Q2), ranked 64 of 216 in Pharmacology (medical). SJR: 0,978.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Clinical Therapeutics is 22%.

Clinical Therapeutics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of Clinical Therapeutics?

What is the APC / publication cost?

What is the acceptance rate?